Microscopic examination of fetal placenta exposed to <i>U.simensis</i> essential oil: D-decidua, DA-decidual artery, DV-decidual vein, blue arrow head-maternal blood space, CBV-cho... by Bickes Wube (21678222)

Subjects:

External examination of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Histopathological scoring of fetal placenta exposed to <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Chemical compositions of <i>U.simensis</i> essential oil identified through GC-MS analysis. by Bickes Wube (21678222)

Subjects:

Axial and extremity bone ossification centers of rat fetuses treated with <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Fetal outcomes of gravid rats treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Fetal growth, anogenital distance and placental weight of rat fetuses treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Developmental scores of cardiovascular and musculoskeletal systems of rat embryos treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Dietary intake and weight gain of pregnant dams treated with <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Implantation and resorption of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil I-implantation, R-resorption, TR-total resorption only in one gravid rat, O-ovary... by Bickes Wube (21678222)

Subjects:

In vivo development of 12-day old rat embryos treated with <i>U.simensis</i> essential oil: VV – vitelline blood vessels, YS-yolk sac, TE- telencephalon, ME-mesencephalon, PA-phary... by Bickes Wube (21678222)

Subjects:

Skeletal ossification of alizarin red stained 20-day old rat fetuses treated with <i>U.simensis</i> essential oil: TL-thoracic and lumbar vertebrae, O-occipital bone, MC-metacarpal... by Bickes Wube (21678222)

Subjects:

All raw data support findings of the study. by Bickes Wube (21678222)

Subjects:

Characteristics of patients who had STI tests, American Family Cohort, 2019-2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia (left) and gonorrhea (right) tests in the American Family Cohort in 2019, 2020, and 2021, age standardized to the U.S. st... by Shiying Hao (659634)

Subjects:

Quarterly test positivity for chlamydia (left) and gonorrhea (right) in the American Family Cohort from 2019 to 2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by gender, age standardized to the U.S. sta... by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021, age standardized to the U.S. standard popu... by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients and the 95% confidence intervals (CIs) for the chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by race/ethnicity, age standardized to the... by Shiying Hao (659634)

Subjects: